Others

Items 8651-8700 of 13502

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Drug Intermediate

    p-Tolualdehyde is a versatile aromatic aldehyde primarily utilized as a key drug intermediate in organic synthesis. Its structure enables various chemical transformations, making it important in the development of pharmaceuticals and agrochemicals. Researchers commonly employ p-Tolualdehyde in the synthesis of biologically active compounds, facilitating advancements in medicinal chemistry.
  2. Drug Intermediate

    2-Carboxy-4-chlorobenzoate, 80% (4,5-DCPA ≤ 20%) Sodium functions as a key drug intermediate in organic synthesis. It is instrumental in the preparation of various biologically active compounds, facilitating research in pharmaceutical development and chemical biology. Its specific structural characteristics enhance its utility in the synthesis of targeted therapeutic agents.
  3. Drug Intermediate

    Sodium 4-methylbenzenesulfonate, a versatile drug intermediate, serves as a key precursor in the synthesis of xanthine oxidase inhibitors. Additionally, it functions as a dopant for the formation of polypyrrole (PPy) conductive films on titanium (Ti) implants, enhancing their biocompatibility and electrical properties. This compound is valuable in pharmaceutical research and materials science applications.
  4. Drug Intermediate

    Tert-Butyl 3-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical agents. Its structural attributes make it valuable for the development of novel therapeutic candidates, facilitating efforts in medicinal chemistry and drug discovery. This compound is instrumental in advancing research focused on creating effective treatments across various disease targets.
  5. Drug Intermediate

    N-Acetylneuraminic Acid Methyl Ester 2,4,7,8,9-Pentaacetate serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This compound plays a significant role in carbohydrate chemistry and glycobiology, facilitating the development of pharmaceuticals and research reagents. Its structural features contribute to various biological activities, making it an essential tool for researchers exploring glycan-related pathways and therapeutic applications.
  6. Drug Intermediate

    4-(1-Aminocyclopropyl)benzonitrile hydrochloride serves as a versatile drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its unique structural features enable the development of compounds with varied biological activities, making it a valuable building block in pharmaceutical research. This reagent is critical for studies focusing on the design and discovery of novel therapeutic agents.
  7. Drug Intermediate

    1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine serves as a crucial intermediate in the synthesis of diverse pharmacologically active compounds. This chemical structure facilitates the development of novel therapeutics through its unique reactivity and functionalization potential. It is particularly valuable in drug discovery and development research aimed at identifying new therapeutic agents.
  8. Drug Intermediate

    P-Toluenesulfonic Acid (3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl Ester serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. This reagent facilitates the formation of complex molecular structures, aiding in the development of pharmaceutical agents. Its application is significant in chemical research aimed at creating innovative therapeutics, particularly those that target various biological pathways.
  9. Drug Intermediate

    Tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-((triisopropylsilyl)ethynyl)naphthalen-2-yl)carbamate serves as a vital drug intermediate in the synthesis of diverse bioactive compounds. This compound facilitates the incorporation of boronate and ethynyl functionalities, making it valuable in medicinal chemistry and drug development applications. Its structural versatility supports the design and optimization of target molecules in pharmaceutical research.
  10. Drug Intermediate

    N-[4-(Trifluoromethyl)benzyl]piperazine is a pharmaceutical intermediate utilized in the synthesis of diverse active compounds. This reagent plays a critical role in the development of various therapeutic agents, particularly in the fields of medicinal chemistry and drug discovery. Its unique trifluoromethyl group enhances the metabolic stability and lipophilicity of the resulting compounds, making it a valuable tool for researchers.
  11. Drug Intermediate

    2-Methylcyclopentane-1,3-dione is a crucial intermediate in the total synthesis of steroid compounds. Its unique structure and reactivity make it valuable for various synthetic pathways in organic chemistry. This reagent is widely utilized in the pharmaceutical industry for the development and manufacturing of steroid-based therapeutics.
  12. Drug Intermediate

    4-Hydroxy-N,N,2-trimethyl-1H-benzimidazole-6-carboxamide serves as a chemical intermediate in pharmaceutical synthesis. This compound is pivotal for the production of various bioactive molecules, facilitating the development of novel therapeutics. Its structural properties support research applications in drug development and medicinal chemistry.
  13. Drug Intermediate

    tert-Butyl 4,7-diazaspiro[2.5]octane-7-carboxylate serves as a versatile drug intermediate in the synthesis of diverse biologically active compounds. Its unique spirocyclic structure lends itself to potential applications in medicinal chemistry and pharmaceutical development. Researchers can utilize this compound to facilitate the construction of novel therapeutic agents.
  14. Drug Intermediate

    4-Pyrimidine methanamine, a synthetic organic compound, serves as an essential drug intermediate in pharmaceutical synthesis. Its structural attributes make it valuable for the development of various biologically active compounds. Researchers can utilize 4-pyrimidine methanamine in the study of pharmacological agents, facilitating the exploration of new therapeutic pathways.
  15. Drug Intermediate

    (1R,2R)-2-(Pyridin-3-yl)cyclopropane-1-carboxylic acid is an important drug intermediate primarily utilized in the synthesis of various active pharmaceutical compounds. This molecule facilitates the development of diverse therapeutic agents, playing a crucial role in medicinal chemistry and drug discovery. Its unique structure allows for tailored modifications that enhance biological activity and specificity in targeting various biological pathways.
  16. Drug Intermediate

    5-Hexenoic acid is a carboxylic acid that serves as a valuable drug intermediate in the synthesis of various pharmaceutical compounds. Its unique structure facilitates the formation of diverse chemical derivatives, making it a crucial component in medicinal chemistry. This reagent is instrumental in advancing research and development in the field of drug discovery.
  17. Drug Intermediate

    Monobenzyl Terephthalate is a versatile drug intermediate primarily utilized in the synthesis of various active pharmaceutical ingredients. Its unique structure facilitates the formation of complex molecules, making it an essential component in chemical research and development. Researchers can employ Monobenzyl Terephthalate for the preparation of diverse therapeutic agents, enabling advancements in medicinal chemistry.
  18. Drug Intermediate Control

    Z-Lys-OMe hydrochloride is a synthetic intermediate primarily used in the synthesis of peptide enzyme substrates. This reagent plays a crucial role in the development of lysine-based cationic surfactants, facilitating research in biochemistry and pharmaceutical applications. Its unique properties make it essential for studies involving peptide synthesis and formulation chemistry.
  19. Drug Intermediate

    2-Fluoropyridine-5-boronic acid is a versatile drug intermediate primarily utilized in the synthesis of fatty acid amide hydrolase inhibitors and pyrethroid derivatives. Its structural integrity supports the development of compounds targeting critical biological pathways involved in pain modulation and insecticide efficacy. This reagent serves as an essential tool for researchers in medicinal chemistry and agricultural sciences, facilitating the discovery of new therapeutic agents and agrochemicals.
  20. Drug Intermediate

    (S)-1-Boc-3-methylpiperazine is a valuable drug intermediate designed for the synthesis of Sotorasib, a targeted therapy for certain cancers. This compound serves as a key building block in multi-step organic synthesis, facilitating the development of potent small molecules. Its role in medicinal chemistry underscores its relevance in pharmaceutical research and development.
  21. Drug intermediate

    6-Bromonicotinaldehyde is a brominated derivative of nicotinaldehyde with potential applications as a key intermediate in organic synthesis. It plays a significant role in the production of Fusaric acid, which is of interest in various biological studies. This compound can aid researchers in developing novel pharmaceuticals and enhancing the understanding of related biochemical pathways.
  22. Drug Intermediate

    (±)-3-Amino-1,2-propanediol is a chiral building block primarily employed as a drug intermediate. It serves as a precursor for the synthesis of chiral vanadium (V) Schiff base complexes, which are important in various chemical applications. Its utility extends to research in asymmetric synthesis and the development of biologically active compounds.
  23. Drug Intermediate

    1-(7-Bromobenzo[d][1,3]dioxol-4-yl)ethan-1-one serves as a vital drug intermediate in the synthesis of diverse bioactive compounds. This compound facilitates the development of novel pharmaceutical agents by enabling the modification of specific molecular structures. Its utility in research supports the exploration of therapeutic candidates across various fields of medicinal chemistry.
  24. Drug Intermediate

    Cis-2-(Methoxycarbonyl)cyclopentanecarboxylic acid serves as a key drug intermediate in the synthesis of various active pharmaceutical compounds. Its structural features facilitate the preparation of compounds with diverse biological activities, making it a valuable reagent in medicinal chemistry research. This compound is utilized in the development of novel therapeutics and enhances the chemical diversity of drug candidates.
  25. Drug Intermediate

    N1,N1-Dimethylpropane-1,2-diamine dihydrochloride is a drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical compounds. This reagent serves as a crucial building block in the development of therapeutics, facilitating the formation of amine-linkages in various chemical reactions. Its role in medicinal chemistry research underscores its significance for applications requiring modifications of organic molecules.
  26. Drug Intermediate

    (2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide serves as a crucial drug intermediate in the synthesis of bioactive compounds. Its unique structural features facilitate the development of novel therapeutic agents, particularly in the realm of antibiotic research. This reagent is invaluable for researchers focused on the design and optimization of pharmaceutical formulations.
  27. Drug Intermediate

    N-(4-Aminophenyl)-N,4-dimethyl-1-piperazineacetamide is a drug intermediate utilized in the synthesis of diverse biologically active compounds. Its structure supports the development of pharmaceuticals through modifications, serving as a building block in medicinal chemistry. This compound is significant for researchers focusing on drug design and development, enabling the exploration of potential therapeutic agents.
  28. Drug Intermediate

    1-Boc-6-Amino-2,3-dihydroindole acts as a versatile drug intermediate, facilitating the synthesis of a range of biologically active compounds. This reagent is instrumental in medicinal chemistry and serves as a building block for the development of novel pharmaceuticals. Its utility in creating indole-derived structures makes it valuable for research applications focused on drug discovery and development.
  29. Drug Intermediate

    (S)-5-Methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride serves as a versatile drug intermediate in the synthesis of various bioactive compounds. This compound facilitates the development of novel therapeutics, enhancing pathways in chemical research. Its unique structural features allow for effective modification and optimization in pharmacological applications.
  30. Product of ADC payload release

    STING agonist-49-CO-C2-mal-Cys is a derivative of the STING agonist designed to facilitate the catabolism of antibody-drug conjugates (ADCs) and promote payload release. This compound exhibits significant antitumor activity in vivo, making it a valuable tool in cancer research. Its unique structure provides essential interactions with target proteins and E3 ligases, contributing to its efficacy in therapeutic applications.
  31. Goserelin Impurity

    Goserelin EP Impurity E is an impurity of Goserelin that serves as a valuable reference standard in analytical chemistry. It is used primarily for the characterization and quality control of Goserelin formulations in pharmaceutical research. This compound aids in assessing the purity and stability of Goserelin, ensuring that drug preparations meet regulatory standards in therapeutic applications.
  32. Drug Intermediate

    4-Chloronaphthalimide is a derivative of naphthalimide that serves as a valuable drug intermediate in pharmaceutical synthesis. This compound plays a crucial role in the development of diverse bioactive molecules due to its reactivity and ability to participate in various chemical transformations. Its applications extend to medicinal chemistry and the exploration of novel therapeutic agents.
  33. Pheromone

    5-Methyldecane is a volatile hydrocarbon identified as a pheromone, primarily sourced from the plant Cordia Africana. This compound has been observed to be released by the marine annelid Platynereis dumerilii, contributing to its role in chemical communication. Its biological activity makes it valuable for research in behavioral ecology and pheromone signaling mechanisms.
  34. Exenatide Impurity

    (D-Asp28)-Exenatide is an impurity of Exenatide, which functions as a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. This compound plays a significant role in the regulation of glucose homeostasis and appetite control, making it relevant for research in diabetes and obesity. The characterization of this impurity is essential for understanding the pharmacological properties and ensuring the quality of Exenatide in therapeutic applications.
  35. Drug Derivative

    N-(4-Hydroxyphenylacetyl)spermine is a drug derivative that acts as a potent cellular growth regulator. It exhibits significant biological activity by modulating polyamine metabolism and influencing cell signaling pathways. This compound is commonly utilized in cancer research to study its effects on cell proliferation and apoptosis, making it a valuable tool for investigating therapeutic strategies in oncology.
  36. Drug Derivative

    L-670,548 is a selective inhibitor of the neurokinin-1 (NK1) receptor, functioning as a drug derivative in research applications. It displays significant anti-nociceptive properties, making it relevant for studies in pain modulation and neurobiology. Researchers utilize L-670,548 to explore the mechanisms of pain signaling and potential therapeutic targets for pain management.
  37. Drug Derivative

    AHN 086 is a small molecule drug derivative that acts as a selective inhibitor of histone deacetylases (HDACs). It exhibits significant anti-proliferative effects in various cancer cell lines by disrupting histone and non-histone protein deacetylation, thus influencing gene expression. This compound is primarily utilized in cancer research and studies investigating epigenetic regulation mechanisms.
  38. Drug Derivative

    SRX251 is a drug derivative that acts primarily as a serotonin receptor antagonist. It demonstrates significant biological activity in modulating serotonergic signaling pathways, which may be relevant in the study of neuropsychiatric disorders. This compound is utilized in research focused on understanding the therapeutic potential of serotonin modulation in various clinical applications.
  39. Drug Derivative

    MDPT (tBuONE) is a derivative of 3',4'-Methylenedioxy-N-tert-butylcathinone, primarily targeting monoamine transporters. This compound exhibits stimulant properties, making it relevant for research focusing on neuropharmacology and the mechanisms of drug addiction. Its structural similarity to known psychoactive substances enables investigations into their pharmacodynamic profiles and potential therapeutic applications.
  40. Drug Derivative

    LB30870 is a drug derivative that demonstrates active pharmacological properties. This compound is utilized in research applications aimed at investigating its potential biological activities and therapeutic effects. Its specific mechanisms and pathways are of interest in the development of novel treatments.
  41. Drug Derivative

    2-Methyl-1-naphthol acts as a crucial precursor in the biosynthesis of Vitamin K3. This compound is relevant for studying Vitamin K deficiency, aiding in the exploration of its implications in various biological processes and potential therapeutic applications. Its derivatives are utilized in research focused on enhancing understanding of Vitamin K's role in health and disease.
  42. Drug Derivative

    NC-1300-B is a potent drug derivative that exhibits significant biological activity through its interaction with specific molecular targets. This compound is primarily used in research focused on drug development and mechanism studies, enabling scientists to explore its therapeutic potential in various disease models. Its specific structural properties make it a valuable tool for investigating novel treatment pathways in pharmacology.
  43. Drug Derivative

    Dactylocycline D is a drug derivative that functions primarily as an antibiotic by inhibiting bacterial protein synthesis. It exhibits potent antibacterial activity against a variety of gram-positive and gram-negative bacteria, making it valuable in pharmacological research focused on antimicrobial mechanisms. This compound is applicable in studies that aim to explore its efficacy, resistance mechanisms, and potential therapeutic uses in infectious diseases.
  44. Impurity

    5′-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine is an impurity associated with the synthesis of Capecitabine. This compound may be used in analytical studies to ensure the purity and quality of Capecitabine preparations. Its identification and characterization contribute to the understanding of the synthesis process and its optimization in pharmaceutical development.
  45. Drug Derivative

    α-Pyrrolidinocyclohexanophenone hydrochloride is a psychostimulant compound primarily targeting the dopamine transporter. It demonstrates notable biological activity as a potent reuptake inhibitor, leading to increased dopaminergic signaling. This compound is primarily utilized in neurological research, particularly in studies exploring the pharmacological effects on mood, cognition, and addiction mechanisms.
  46. Drug Derivative

    4-Hydroxyisophorone is a derivative of abscisic acid that exhibits a weak inhibitory effect on plant growth. This compound is utilized in research to explore plant hormone interactions and their physiological effects. It serves as a valuable tool for investigating the mechanisms of plant development and response to environmental stressors.
  47. Drug Derivative

    (R)-ADR 882, a derivative of the drug class, exhibits potent biological activity by interacting with specific cellular targets. This compound is primarily utilized in research applications focused on pharmacological studies and the development of therapeutic agents. Its efficacy in modulating biological pathways makes it a valuable tool for investigating disease mechanisms and evaluating potential drug candidates.
  48. Drug Derivative

    SKF 83692 is a potent derivative that primarily targets dopamine receptors, specifically D1-like receptors. This compound exhibits notable biological activity in modulating dopaminergic signaling, making it valuable for research in neuropharmacology and the study of dopamine-related disorders. SKF 83692 serves as an important tool for investigating receptor pharmacology and the potential therapeutic effects of dopamine modulation in various neurological conditions.
  49. Drug Derivative

    N-Cyclohexanecarbonyltetradecylamine is an analog of N-cyclohexanecarbonyl-pentadecylamine that functions as a selective inhibitor of acidic phosphoethanolaminease (PEAase). This compound exhibits significant biological activity in modulating lipid metabolism and has applications in biochemical research focusing on enzyme inhibition and metabolic regulation. Its use may provide insights into the therapeutic potential for disorders related to lipid homeostasis.
  50. Drug Derivative

    Triazamate is a drug derivative that interacts with various biological targets to exhibit pharmacological activity. It demonstrates potential applications in the study of drug metabolism and pharmacokinetics, offering insights into therapeutic mechanisms and efficacy. This compound serves as a valuable tool for researchers investigating drug action and development in the field of medicinal chemistry.

Items 8651-8700 of 13502

Page
per page
Set Descending Direction